What Blood Test Is Used to Check Your Liver?

The standard blood test used to check your liver is called a liver function panel, sometimes labeled a hepatic function panel or simply “LFTs” on your lab order. It typically includes a handful of enzymes and proteins: alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), bilirubin, and albumin. Depending on the clinical situation, a prothrombin time (PT/INR) is often added. But what these tests actually measure, and what they miss, is more nuanced than most people realize.

What Each Test in the Liver Panel Measures

Despite the name “liver function tests,” most of the enzymes in the panel do not measure how well your liver is functioning. They measure liver injury. When liver cells are damaged or inflamed, they leak enzymes into the bloodstream, and the lab detects that spillover. True measures of liver function, like albumin and clotting time, tell you whether the organ is actually doing its job of making proteins and processing waste. Keeping that distinction straight helps you understand why your doctor might order additional tests even when your “liver function” results look normal.

ALT is the most liver-specific enzyme in the standard panel. It lives primarily in liver cells, so when it shows up at elevated levels in your blood, the signal points fairly directly at the liver. AST is less specific because it also exists in heart muscle, skeletal muscle, kidneys, and red blood cells. A high AST with a normal ALT can sometimes reflect a problem outside the liver entirely. Both enzymes rise when liver cells are injured by infection, medication, alcohol, or fat accumulation.

Alkaline phosphatase behaves differently. It rises when bile flow is impaired, a pattern doctors call cholestatic disease. In that scenario, ALP climbs to levels several times the upper limit of normal, while the transaminases (ALT and AST) may only bump up modestly.¹ ALP is also found in bone and the placenta, so an elevated reading does not automatically implicate the liver. That is where GGT comes in: if both ALP and GGT are elevated together, the source is almost certainly the liver or bile ducts rather than bone. An elevated ALP with a normal GGT often points clinicians toward a bone-related cause instead.²

Bilirubin is a yellow pigment produced when old red blood cells break down. The liver processes it, conjugates it, and sends it into bile. When the liver is damaged or bile flow is blocked, bilirubin builds up in the blood, eventually turning the skin and eyes yellow (jaundice). Your lab report may split bilirubin into “direct” (conjugated) and “indirect” (unconjugated) fractions. High indirect bilirubin with otherwise normal liver enzymes can point toward conditions unrelated to liver disease, like Gilbert syndrome, a harmless genetic quirk that affects roughly one in twenty people. High direct bilirubin is more worrisome because it suggests the liver or bile ducts are having trouble moving bile out.³

Measuring Actual Liver Function

Albumin and prothrombin time get closer to the question of whether the liver is working properly. Albumin is a protein the liver produces in large quantities. When the liver is severely damaged or chronically diseased, albumin production drops and blood levels fall. Low albumin can also result from kidney disease, malnutrition, or chronic inflammation, so it is not specific to the liver on its own, but in the context of other abnormal liver tests it adds an important piece to the puzzle.

Prothrombin time measures how quickly your blood forms a clot. The liver manufactures most of the clotting factors involved in this process, so when it fails, clotting slows and the PT or its standardized version, the INR, rises. The PT-INR is considered a robust measure of liver function, though labs can produce slightly different INR results depending on the reagents they use.⁴ In acute liver failure, the INR is one of the most important prognostic markers, and among specific clotting factors, factor X levels have been found to correlate well with outcomes.⁵ For most routine checkups, though, a simple PT/INR alongside the rest of the panel is sufficient.

The AST-to-ALT Ratio and Why It Matters

Your doctor may not just look at the individual enzyme numbers but at how they relate to each other. The ratio of AST to ALT can help distinguish between different causes of liver disease. In one well-known study, patients with nonalcoholic fatty liver inflammation (NASH) had a mean AST-to-ALT ratio of about 0.9, while patients with alcoholic liver disease had a mean ratio of about 2.6. The difference between the two groups was highly significant. As a rule of thumb, a ratio below 1 leans toward a nonalcoholic cause, while a ratio of 2 or higher strongly suggests alcohol-related damage.⁶

This ratio is not a definitive diagnostic tool on its own, but it helps clinicians narrow down the possibilities before ordering more expensive or invasive tests. It also explains why your lab report might show both AST and ALT even though ALT alone is the more liver-specific enzyme. Each one adds context the other cannot provide.

When Normal Results Can Be Misleading

One of the most important things to understand about liver blood tests is that normal results do not guarantee a healthy liver. This is especially relevant for fatty liver disease, now the most common chronic liver condition in many countries. In a study of patients with confirmed fatty liver on biopsy, about a quarter had completely normal ALT levels. Among that normal-ALT group, over a third still had either significant liver inflammation or advanced scarring (fibrosis). Meanwhile, more than half of the patients with elevated ALT turned out to have neither advanced inflammation nor fibrosis.⁷ In other words, ALT is neither sensitive enough to catch everyone with serious disease nor specific enough to avoid false alarms.

A separate study of patients with impaired glucose tolerance and newly diagnosed type 2 diabetes found that over half of those with fatty liver on imaging had ALT values within what labs typically call the “normal” range. The same was true for GGT: more than half of affected patients had readings that would not trigger concern on a routine panel.⁸ This is why clinicians increasingly rely on additional scoring systems and imaging to catch liver disease early, rather than trusting the basic panel alone.

Fibrosis Scores Built from Routine Blood Work

If your doctor suspects that liver damage has been going on long enough to cause scarring, they may calculate a fibrosis score using numbers that are already sitting in your standard blood work. The most widely used is the FIB-4 index, which combines your age, platelet count, AST, and ALT into a single number. No extra blood draw is needed. A low FIB-4 score reliably rules out advanced fibrosis in most people, while a high score flags those who need further evaluation, such as specialized imaging or a liver biopsy.

In a large primary-care study, patients with high-risk FIB-4 scores had roughly a six-and-a-half-fold higher chance of experiencing severe liver outcomes compared with low-risk patients. About 20% of those with high-risk scores went on to develop a serious liver complication, versus just 2% in the low-risk group.⁹ Some screening programs now automatically calculate FIB-4 from routine lab results and flag any score of 1.3 or above for further testing, such as a specialized blood marker called the ELF test or an imaging-based stiffness measurement.¹⁰

When FIB-4 is combined with clinical risk scoring, its predictive power sharpens further. In a population-based study, people who were already classified as high clinical risk and who also had a high FIB-4 score had a ten-year cumulative incidence of severe liver outcomes above 21%, whereas high clinical risk with a low FIB-4 dropped that figure to under 2%.¹¹ This layered approach is reshaping how primary care doctors think about liver screening: instead of waiting for enzymes to spike, they can catch fibrosis quietly progressing in patients whose standard panel looks unremarkable.

Things That Throw Off Your Results

Before panicking over a mildly abnormal liver test, it helps to know what else can push those numbers around. Vigorous exercise is one of the most common and least recognized culprits. In a study of healthy men, a single bout of strenuous physical activity raised AST, ALT, and several other markers to levels that would look alarming on a lab report, and those elevations persisted for at least seven days after the workout. Bilirubin, GGT, and ALP, by contrast, stayed within normal limits.¹² If you hit the gym hard a few days before a blood draw, your doctor might see transaminase levels that suggest liver injury when in reality your muscles are just recovering.

Many common medications can also elevate liver enzymes, including over-the-counter painkillers like acetaminophen, certain antibiotics, statins, and some herbal supplements. Alcohol consumed within a day or two of the blood draw can bump numbers as well. Fasting versus non-fasting status has a smaller effect on most liver enzymes than it does on glucose or lipids, but your doctor may still ask you to fast if they are looking at a comprehensive metabolic panel that includes both.

Liver Tests During Pregnancy

Pregnancy creates its own set of challenges for interpreting liver blood work. Abnormal liver tests show up in roughly 3 to 5% of pregnancies, and the causes range from harmless to life-threatening.¹³ Normal pregnancy itself alters several baseline values. Albumin falls because of blood volume expansion, ALP rises because the placenta produces its own version of the enzyme, and the upper limits for ALT and AST may be slightly lower than in non-pregnant adults.

The concerning conditions are distinct to pregnancy. Preeclampsia and its severe variant HELLP syndrome cause transaminase spikes along with low platelets and evidence of red blood cell destruction. Intrahepatic cholestasis of pregnancy (ICP) drives up bile acids and bilirubin and causes intense itching, usually in the third trimester. Acute fatty liver of pregnancy (AFLP) is rare but can progress rapidly to liver failure.¹⁴ The pattern of which tests are elevated helps distinguish these conditions. In a study of pregnant women with abnormal liver tests, bilirubin was moderately elevated in hypertensive disorders but climbed highest in viral hepatitis, while ALP peaked in cholestasis of pregnancy.¹⁵ Because the stakes are high for both mother and baby, any abnormal liver test during pregnancy typically triggers prompt follow-up rather than watchful waiting.

When Elevated ALT Leads to a Hepatitis Workup

If your liver enzymes come back elevated and there is no obvious explanation like a new medication or a weekend of heavy drinking, your doctor will likely check for viral hepatitis. Hepatitis B and hepatitis C are the two infections most commonly screened for, using antibody and antigen blood tests rather than the liver panel itself. The liver panel is what raises the suspicion; the viral tests confirm or rule out the cause.

This matters more than people think. A primary-care study that tested anonymous blood samples from patients with mildly elevated ALT found that among those with levels between 50 and 100 IU/L, hepatitis C prevalence was roughly ten times the background rate in the general population. Hepatitis B prevalence, interestingly, was not elevated in the same group.¹⁶ The takeaway is that even modest, easy-to-dismiss ALT elevations can be the first clue to an undiagnosed chronic infection, and the follow-up tests are simple blood draws that can be added to the same visit.

Autoimmune Liver Disease and Specialized Antibody Tests

When viral hepatitis, alcohol, medications, and fatty liver disease have all been ruled out, unexplained liver enzyme elevations sometimes lead to testing for autoimmune liver conditions. Autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis are the three main forms, and they each have characteristic antibody signatures that can be detected through blood tests.

Autoimmune hepatitis type 1 is associated with antinuclear antibodies (ANA) and smooth muscle antibodies (SMA). Type 2 involves antibodies against a specific liver-kidney enzyme (anti-LKM1). Primary biliary cholangitis is strongly linked to antimitochondrial antibodies (AMA). Primary sclerosing cholangitis, by contrast, does not have a reliable autoantibody marker, making it harder to diagnose with blood work alone.¹⁷ These antibody tests are not part of the routine liver panel. They are ordered when the clinical picture suggests an autoimmune cause, and they work best alongside imaging and sometimes biopsy to confirm the diagnosis.¹⁸

Early detection matters here because autoimmune hepatitis and primary biliary cholangitis respond to treatment, and starting therapy before the disease progresses to cirrhosis significantly improves long-term outcomes. If your doctor orders an ANA or SMA test alongside your liver panel, it is usually because they are being thorough rather than alarmed.

Why Reference Ranges Differ for Children

If you are looking at a child’s liver test results, the reference ranges printed on an adult lab report can be misleading. Liver enzyme levels in children and adolescents follow age- and sex-specific patterns that shift as the child grows, particularly around puberty. A study that established pediatric percentiles for ALT, AST, and GGT found that body mass index and pubertal stage both influenced enzyme concentrations significantly.¹⁹ For example, AST tends to be higher in young children and declines with age, while GGT may rise during puberty in boys. A value that looks borderline-high using an adult cutoff might be perfectly normal for a twelve-year-old, and vice versa. Pediatricians typically use age-adjusted charts, but parents reviewing lab results at home may not realize the printed range does not apply to their child.

GGT as a Standalone Marker

GGT deserves separate mention because it occupies an odd space in liver testing. It is extremely sensitive to liver and biliary problems, but it is also sensitive to alcohol use, certain medications, obesity, and even pancreatic disease. That lack of specificity means a high GGT on its own does not tell you much, but it becomes valuable in combination. As mentioned earlier, it confirms a hepatic origin when ALP is elevated. It also serves as one of the better blood markers for heavy alcohol consumption, often rising before other liver enzymes do. In the context of fatty liver disease, GGT elevation alongside ALT adds predictive value for identifying patients at higher risk.⁸ Some researchers have also explored GGT as an independent predictor of cardiovascular disease and metabolic syndrome, though those connections go beyond the liver-specific question.

What Happens After an Abnormal Result

A single mildly elevated liver enzyme reading rarely triggers aggressive investigation. Most doctors will recheck the panel in a few weeks, ask about medications, supplements, alcohol, and recent exercise, and look at the pattern of which tests are elevated. A hepatocellular pattern, where ALT and AST are the dominant elevations, points toward liver cell injury from causes like viral hepatitis, medications, or fatty liver. A cholestatic pattern, where ALP is the standout elevation with relatively modest transaminase changes, points toward bile duct obstruction or infiltrative diseases.¹ A mixed pattern requires broader investigation.

If the repeat tests stay abnormal, the next steps usually involve viral hepatitis serology, an abdominal ultrasound, and possibly iron studies or autoimmune markers depending on the clinical suspicion. Imaging can reveal fatty infiltration, tumors, bile duct dilation, or signs of cirrhosis that blood tests alone cannot detect. A liver biopsy remains the gold standard for grading inflammation and staging fibrosis, but non-invasive approaches like FIB-4 scoring and elastography (a specialized ultrasound measuring liver stiffness) have reduced the need for biopsy in many situations. The blood panel is the entry point, not the endpoint, of liver evaluation.